Ontology highlight
ABSTRACT: Background
Treatment with growth hormone (GH) is standard clinical practice in children with GH deficiency (GHD) or Turner syndrome (TS). Hitherto, no long-term data on auxological outcome and safety of Zomacton® have been published. Data comparing needle-free administration (NF) and needle injection (NI) of GH are very sparse.Aims
To analyse longitudinal auxological outcome and safety data of GH treatment-naïve patients diagnosed with GHD or TS and to compare NF and NI in a real-life setting.Methods
Pooled auxological data and safety information from three consecutive prospective observational Zomacton® studies covering 22 years of treatment were analysed and NF was compared to NI.Results
The safety cohort comprised 1,595 patients who received at least one
SUBMITTER: Rohrer TR
PROVIDER: S-EPMC6561679 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature